EUVIMEDFaigh amach EUVIMED
Open access

Expression and clinical significance of ECHS1 in gastric cancer

Ting Lu, Liang Sun, Qingmin Fan, Junchen Yan, Dan Zhao, Chunfang Xu, Fenglin Dong

Journal of Cancer · 2024 · 15 (2) · 418-427

DOI: 10.7150/jca.88604 ↗

At a glance

Journal article in Journal of Cancer, 2024. Written by Ting Lu and 6 co-authors. Institution: Department of Ultrasound, the First Affiliated Hospital of Soochow University, Suzhou 215006, China. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central.

AchoimreSonraí leabharliostaCiteRelated studies

Abstract (original language)

Background

Gastric cancer (GC), as one of the most common malignant tumors and the 3rd primary cause of death by cancer globally, poses a great threat to public health. Despite many advancements have been achieved in current treatment avenues for GC, the 5-year survival rates of GC patients remain substandard. Short-chain enoyl-CoA hydratase (ECHS1) exerts pro- or anti-cancer activities in different cancer backgrounds. However, its clinical significance and biological role in GC remain vague and need further investigation.

Methods

The expression of ECHS1 in GC tumors and adjacent normal tissues was examined using the GEPIA platform and clinical samples. The effects of ECHS1 on GC cell proliferation and migration were evaluated using colony formation and transwell migration assays.

Results

ECHS1 was upregulated in GC tumor tissues in both mRNA and protein levels and increased ECHS1 was markedly linked with tumor location, depth of tumor invasion, lymph node metastasis (LNM), and tumor-node-metastasis (TNM) stage of GC patients. High ECHS1 expression was also linked with a shorter overal survival (OS), first progression (FP) and post progression survival (PPS). Further subgroup analysis showed that OS was significantly shorter in GC patients with high ECHS1 expression compared to those with low ECHS1 expression belonging to tumors with T3 stage, N2 stage or in instestinal Lauren subgroup. In addition, cytological experiments showed that there was higher ECHS1 expression in GC cell lines compared to the normal gastric epithelium (GES-1) cells, and ECHS1 can promote GC cell proliferation and migration in vitro.

Conclusion

ECHS1 plays an oncogenic role in GC and might be a promising therapeutic target for GC.

Authors and institutions

  • Department of Ultrasound, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Department of General Surgery, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Department of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.

Cite

APA

Lu, T., Sun, L., Fan, Q., Yan, J., Zhao, D., Xu, C., & Dong, F. (2024). Expression and clinical significance of ECHS1 in gastric cancer. Journal of Cancer, 15(2), 418-427. https://doi.org/10.7150/jca.88604

Vancouver

Lu T, Sun L, Fan Q, Yan J, Zhao D, Xu C, et al. Expression and clinical significance of ECHS1 in gastric cancer. Journal of Cancer. 2024;15(2):418-427. doi:10.7150/jca.88604

BibTeX
@article{Lu2024,
  author = {Lu, Ting and Sun, Liang and Fan, Qingmin and Yan, Junchen and Zhao, Dan and Xu, Chunfang and Dong, Fenglin},
  title = {Expression and clinical significance of ECHS1 in gastric cancer},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {2},
  pages = {418--427},
  doi = {10.7150/jca.88604}
}
Start for free →